Product
Antithymocyte globulin
Aliases
Antithymocyte globulin (ATG)
2 clinical trials
2 indications
Indication
Transplant RejectionIndication
Myeloid DiseasesClinical trial
A Multi-cohort, Randomized, Phase 2, Open-label Study to Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of BIVV020 for Prevention and Treatment of Antibody-mediated Rejection in Adult Kidney Transplant Recipients.Status: Recruiting, Estimated PCD: 2024-11-14
Clinical trial
Allogeneic Hematopoietic Stem Cell Transplantation of α/β T-Lymphocyte Depleted Graft Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic AnemiaStatus: Active (not recruiting), Estimated PCD: 2025-05-01